GLP
FDA approves Wegovy pill for weight loss, providing an oral option
FDA approves oral Wegovy (semaglutide) for weight loss; similar efficacy to injectable, with GI side effects and cost noted.
Foods to Eat with GLP-1 Medications
Protein, fiber and healthy fats to pair with GLP-1 meds—what to eat to reduce side effects, preserve muscle, and stabilize blood sugar.
5 Common Mistakes When Using GLP-1 for Weight Loss
Five common GLP-1 mistakes—missed doses, low protein, stopping early, extreme calorie cuts, and using meds without medical supervision—and how to avoid them.
How to Stay Motivated During GLP-1 Treatment
Practical strategies to stay motivated during GLP-1 treatment—set goals, manage side effects and plateaus, build routines, and use support to sustain weight loss.
Common Misconceptions About GLP-1 Weight Loss
Explains how GLP‑1 drugs aid weight loss, common myths, side effects, who shouldn’t take them, and why lifestyle plus medical oversight matters.
Cardiovascular Risks of GLP-1 Medications
Clear overview of GLP-1 receptor agonists’ heart benefits and risks, with monitoring tips, drug interactions, and patient selection for safer use.
Novo Nordisk submits application for FDA approval of CagriSema for weight management
Novo Nordisk submits NDA to US FDA for once-weekly CagriSema for weight management based on REDEFINE trials.
EMA approves Mounjaro’s use for children as young as ten for diabetes management
EMA recommends Mounjaro for children aged 10+ with type 2 diabetes to improve blood sugar and aid weight loss.
Tirzepatide: Dual Action for Weight Loss
Compare tirzepatide and semaglutide weight-loss effects, visceral fat reduction, side effects, and costs to decide which therapy fits your health priorities.
